The National Pharmaceutical Pricing Authority (NPPA) on November 27, 2025, notified regarding the withdrawal of the draft notification w.r.t. M/s Sun Pharma Laboratories Ltd.
It states that NPPA has withdrawn the draft notification issued on November 14, 2025, stating the price fixation of each uncoated bilayered tablet containing: Metformin Hydrochloride IP 500 mg (As sustained release) + myo-Inositol IP 600 mg for M/s Akums Drugs & Pharmaceuticals Ltd. (Manufacturer) & M/ Sun Pharma Laboratories Ltd. (Marketer).
[Notification no. - 19(4856)/2025/DP/NPPA/Div.II]